Assessment of NAFLD cases and its correlation to BMI and metabolic syndrome in healthy blood donors in kerman

Gastroenterology and Hepatology from Bed to Bench

Volumn 5, Issue 4, 2012, Pages 183-189

  Lahsaee, Sadroddin ^a   Ghazizade, Alireza ^b   Yazdanpanah, Mahnaz ^a   Enhesari, Ahmad ^a   Malekzadeh, Reza ^c  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Blood donors; Body mass index; Metabolic syndrome; Non alcoholic fatty liver disease

Indexed keywords

ALANINE AMINOTRANSFERASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD DONOR; BODY MASS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; PERMIAN; PREVALENCE; RANDOM SAMPLE;

EID: 84869075519     PISSN: 20082258     EISSN: 20084234     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. th edition. New York: Saunders Elsevier; 2006. P.1793-94.
2. Biornsson E. The clinical aspects of non-alcoholic fatty liver disease. Minerva Gastroentrol Dietol 2008; 54:7-18.
3. Jov D, Thava VR, Scott BB. Diagnosis of fatty liver disease: is biopsy necessary? Eur J Gastroenterol Hepatol 2003;15:539-43.
4. Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999;29:664-69.
5. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, et al. Expanding the natural history of non-alcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002;23:134-40.
6. Pourshams A, Malekzadeh R, Monavvari A, Akbari MR, Mohamadkhani A, Yarahmadi S, et al. Prevalence and etiology of persistently elevated alanine aminotransferase level in healthy Iranian blood donors. J Gastroenterol Hepatol 2005;20:229-33.
7. US Department of Health and Human Services. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Washington, DC: US Department of Health and Human Services; 1998.
8. National Cholesterol Education Program (NCEP) Expert on detection, evaluation and treatment of high blood cholesterol in adults. (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-44.
9. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complication. Part 1: diagnosis and classification of diabetes mellitus provisional report of WHO consultation. Diabetes Med 1998; 15:539-53.
10. Parulekar SG, Bree RL. Liver. In: MC Gahan JP, Goldberg BB. Diagnostic ultrasound: a logical approach. Philadelphia: Lippincott-Raven 1998;599-91.
11. Limanond P, Raman SS, Lassman C, Sayre J, Ghobrial RM, Busuttil RW. Macro vesicular Hepatic Steatosis in living related liver fonors: correlation between CT and histologic findings. Radiology 2004; 230:276-80.
12. Raptopoulos V, Karellas A, Bernstein J, Reale FR, Constantinou C, Zawacki JK. Value of dual-energy CT indifferentating Focal Fatty infiltration of the liver from low-density masses. AJR AMJ Roentgenol 1991;157:721-25.
13. Kamel IR, Kruskal JB, Raptopoulos V. Imaging for right lobe living donor liver transplantation. Semin Liver Dis 2001;21:271-82.
14. Anderson NA, Raafat A, Shwe KH, Barbara J, Contreras M, Fraser ID, et al. UK multicenter study on blood donors for surrogate marker of non-A nin-B hepatitis. Part I: alanine transferase and anti-HBC testing. Transfus Med 1992; 2:301-10.